Investigating how a specific protein helps heal lung injuries
Transcription Factor Elf2 Signals Resolution of Lung Injury
This study is looking at how a protein called Elf2, which is influenced by calcium, can help heal lung injuries caused by inflammation, and it aims to find new ways to treat people with acute lung injury.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10793513 on NIH RePORTER |
What this research studies
This research focuses on understanding how the transcription factor Elf2, regulated by calcium-dependent signaling, can promote healing in lung injuries caused by inflammation. The study will explore the role of Elf2 in enhancing the expression of important proteins that maintain the integrity of blood vessels in the lungs. By using animal models and analyzing genetic expressions, the researchers aim to uncover mechanisms that could lead to new treatments for acute lung injury. Patients with acute lung injury may benefit from insights gained through this research, potentially leading to improved therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from acute lung injury or related inflammatory lung conditions.
Not a fit: Patients with chronic lung diseases that are not primarily inflammatory in nature may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance recovery from acute lung injuries.
How similar studies have performed: Previous studies have shown promising results in understanding the role of similar signaling pathways in lung injury, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Tiruppathi, Chinnaswamy — University of Illinois at Chicago
- Study coordinator: Tiruppathi, Chinnaswamy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.